BACKGROUND: Despite clear evidence for the efficacy of lowering @entity165 levels, there is a deficiency in its real-world application. There is a need to explore alternative strategies to address this important public health problem. This study aimed to determine the effect of a program of community pharmacist intervention on the process of @entity165 risk management in @entity1 at high risk for cardiovascular events. METHODS: A randomized controlled trial conducted in 54 community pharmacies (1998-2000) included @entity1 at high risk for cardiovascular events (with @entity731 or @entity6 with another risk factor). @entity1 randomized to pharmacist intervention received education and a brochure on risk factors, point-of-care @entity165 measurement, referral to their physician, and regular follow-up for 16 weeks. Pharmacists faxed a simple form to the primary care physician identifying risk factors and any suggestions. Usual care @entity1 received the same brochure and general advice only, with minimal follow-up. The primary end point was a composite of performance of a fasting @entity165 panel by the physician or addition or increase in dose of @entity165 -lowering medication. RESULTS: The external monitoring committee recommended early study termination owing to benefit. Of the 675 @entity1 enrolled, approximately 40% were @entity1 , and the average age was 64 years. The primary end point was reached in 57% of intervention @entity1 vs 31% in usual care (odds ratio, 3.0; 95% confidence interval, 2.2-4.1; P<.001). CONCLUSIONS: A community-based intervention program improved the process of @entity165 management in high-risk @entity1 . This program demonstrates the value of community pharmacists working in collaboration with @entity1 and physicians.

A randomized trial of the effect of community pharmacist intervention on XXXX risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).

@entity1 :: ('9606', 'Species') :: ['women', 'Patients', 'patients'] @entity731 :: ('MESH:D050197', 'Disease') :: ['atherosclerotic disease'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes mellitus'] @entity165 :: ('MESH:D002784', 'Chemical') :: ['cholesterol']
@entity165 :: (MESH:D002784,Chemical) :: ['cholesterol']
